Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 873630 LONDON, X0
Back to REGN Full portfolio

Position in REGN

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$249,823,869
+$3,745,544 QoQ
Shares Held
323,338
+1.4% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2026
CallValue
$1,545,280
CallShares
2,000
PutValue
$10,044,320
PutShares
13,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $961,896,281 across 121 Biotechnology names. REGN ranks #2 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 655,443 $292,681,510
2 REGN
Regeneron Pharmaceuticals, Inc.
This page 		323,338 $249,823,869
3 RPRX
Royalty Pharma plc
 1,544,018 $74,066,541
4 INCY
Incyte Corp
 582,368 $54,812,474
5 ALNY
Alnylam Pharmaceuticals, Inc.
 89,619 $29,652,235
6 MRNA
Moderna, Inc.
 490,088 $24,896,468
7 INSM
INSMED Inc
 116,456 $19,042,883
8 PTCT
Ptc Therapeutics, Inc.
 227,059 $15,469,528

All Filings in REGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,044,320 13,000
2026-03-31 $1,545,280 2,000
2026-03-31 $249,823,869 323,338
2025-12-31 $1,852,488 2,400
2025-12-31 $1,543,740 2,000
2025-12-31 $246,078,325 318,808
2025-09-30 $3,317,393 5,900
2025-09-30 $208,020,216 369,965
2025-06-30 $630,000 1,200
2025-06-30 $190,115,100 362,124
2025-03-31 $247,094,735 389,598
2025-03-31 $761,076 1,200
2024-12-31 $9,189,057 12,900
2024-12-31 $13,819,202 19,400
2024-12-31 $309,011,599 433,804
2024-09-30 $375,380,980 357,084
2024-09-30 $26,386,124 25,100
2024-09-30 $10,617,524 10,100
2024-06-30 $22,492,042 21,400
2024-06-30 $384,598,148 365,925
2024-06-30 $26,380,853 25,100
2024-03-31 $24,254,748 25,200
2024-03-31 $30,029,688 31,200
2024-03-31 $363,268,748 377,426
2023-12-31 $285,454,786 325,012
2023-12-31 $40,489,169 46,100
2023-12-31 $14,843,101 16,900
2023-09-30 $221,377,883 269,002
2023-09-30 $34,399,728 41,800
2023-09-30 $19,257,264 23,400
2023-06-30 $217,475,469 302,663
2023-06-30 $16,454,566 22,900
2023-06-30 $26,154,856 36,400
2023-03-31 $11,503,380 14,000
2023-03-31 $7,723,698 9,400
2023-03-31 $210,183,183 255,800
2022-12-31 $2,453,066 3,400
2022-12-31 $185,859,428 257,605
2022-12-31 $1,082,235 1,500
2022-09-30 $1,033,305 1,500
2022-09-30 $127,963,799 185,759
2022-09-30 $3,651,011 5,300
2022-06-30 $93,021,987 157,363
2022-06-30 $1,714,277 2,900
2022-06-30 $1,477,825 2,500
2022-03-31 $2,234,944 3,200
2022-03-31 $63,653,298 91,139
2022-03-31 $209,526 300
2021-12-31 $3,852,272 6,100
2021-12-31 $61,213,232 96,930

Report a Problem

Category
Description
Email (optional, for follow-up)